Exane Derivatives’s AB InBev BUD Stock Holding History

Exane Derivatives’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$324	Hold	6	–	–	﹤0.01%	626
2022 Q1	$360	Hold	6	–	–	﹤0.01%	904
2021 Q4	$363	Hold	6	–	–	﹤0.01%	803
2021 Q3	$338	Hold	6	–	–	﹤0.01%	977
2021 Q2	$417	Buy	+6	New	+$438	﹤0.01%	959
2021 Q1	–	Sell	-4,077	Closed	-$285K	–	930
2020 Q4	$285K	Buy	4,077 +3,427	+527%	+$217K	0.08%	254
2020 Q3	$35K	Hold	650	–	–	0.01%	394
2020 Q2	$32K	Buy	+650	New	+$30.4K	0.01%	381
2019 Q4	–	Sell	-79,505	Closed	-$6.62M	–	687
2019 Q3	$7.56M	Buy	79,505 +14,690	+23%	+$1.39M	1.36%	16
2019 Q2	$5.73M	Buy	64,815 +50,125	+341%	+$4.3M	1.01%	19
2019 Q1	$1.23M	Buy	+14,690	New	+$1.13M	0.24%	92
2018 Q4	–	Sell	-47,261	Closed	-$3.62M	–	684
2018 Q3	$4.13M	Sell	47,261 -38,907	-45%	-$3.79M	0.77%	27
2018 Q2	$8.69M	Buy	86,168 +37,976	+79%	+$3.77M	1.45%	13
2018 Q1	$5.29M	Buy	+48,192	New	+$5.34M	1.06%	18
2017 Q4	–	Sell	-6,195	Closed	-$729K	–	614
2017 Q3	$739K	Sell	6,195 -20,369	-77%	-$2.39M	0.14%	103
2017 Q2	$2.93M	Sell	26,564 -21,070	-44%	-$2.41M	0.63%	33
2017 Q1	$5.23M	Sell	47,634 -59,467	-56%	-$6.39M	1.18%	17
2016 Q4	$11.3M	Buy	107,101 +81,529	+319%	+$9.14M	2.23%	9
2016 Q3	$3.36M	Sell	25,572 -56,699	-69%	-$7.16M	0.5%	51
2016 Q2	$10.8M	Buy	82,271 +37,405	+83%	+$4.71M	1.79%	27
2016 Q1	$5.59M	Buy	44,866 +34,159	+319%	+$4.05M	0.74%	40
2015 Q4	$1.34M	Buy	10,707 +6,707	+168%	+$812K	0.18%	71
2015 Q3	$425K	Buy	+4,000	New	+$464K	0.05%	136

Other funds holding BUD

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BCF

BLS Capital Fondsmaeglerselskab Klampenborg, Denmark $2.94B AUM 13.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Exane Derivatives's BUD Position: Q2 2022 in Review

Exane Derivatives held its AB InBev (BUD) position steady in Q2 2022 at 6 shares worth $324. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Exane Derivatives first reported a position in BUD in Q3 2015 and has held it in 23 quarters since. The position peaked at $11.3M in Q4 2016. 514 funds tracked by Wall St. Rank hold BUD as of Q2 2022.

Exane Derivatives held 6 shares of AB InBev worth $324 as of Q2 2022.
Exane Derivatives left its AB InBev share count unchanged in Q2 2022.
AB InBev made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #626 holding.
Exane Derivatives first reported a position in AB InBev in Q3 2015 and has held it in 23 quarters since.
Exane Derivatives's AB InBev position peaked at $11.3M in Q4 2016.
514 funds tracked by Wall St. Rank held AB InBev as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.